1. Home
  2. TWIN vs CRBP Comparison

TWIN vs CRBP Comparison

Compare TWIN & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$15.79

Market Cap

224.5M

Sector

Industrials

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.02

Market Cap

202.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
CRBP
Founded
1918
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.5M
202.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TWIN
CRBP
Price
$15.79
$10.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$12.00
$50.29
AVG Volume (30 Days)
30.0K
280.2K
Earning Date
11-05-2025
11-12-2025
Dividend Yield
1.03%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$347,837,000.00
N/A
Revenue This Year
$10.79
N/A
Revenue Next Year
$8.43
$100.00
P/E Ratio
$841.48
N/A
Revenue Growth
14.24
N/A
52 Week Low
$6.16
$4.64
52 Week High
$17.08
$20.56

Technical Indicators

Market Signals
Indicator
TWIN
CRBP
Relative Strength Index (RSI) 56.99 36.05
Support Level $15.44 $10.10
Resistance Level $16.27 $10.82
Average True Range (ATR) 0.61 0.68
MACD 0.05 -0.01
Stochastic Oscillator 85.85 8.91

Price Performance

Historical Comparison
TWIN
CRBP

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: